IP Library Patent Application 19353364
Patent Application
App. No. 19/353,364

TISSUE SUBSTITUTE MATERIALS AND METHODS FOR TISSUE REPAIR

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
19/353,364
Abstract

Non-woven graft materials for use in specialized surgical procedures such as neurosurgical procedures, methods for making the non-woven graft materials, and methods for repairing tissue such as neurological tissue using the non-woven graft materials are disclosed. More particularly, disclosed are non-woven graft materials including at least two distinct fiber compositions composed of different polymeric materials, methods for making the non-woven graft materials and methods for repairing tissue in an individual in need thereof using the non-woven graft materials.

Claims (37)

1 - 20 . (Canceled)

21 . A resorbable fiber matrix comprising:

a first non-woven fiber composition and a second non-woven fiber composition, wherein the first and second non-woven fiber compositions each independently comprise a resorbable polymer;

wherein the resorbable fiber matrix comprises:

a plurality of pores,

a plurality of protrusions,

a plurality of depressions, and

an architecture resembling a native extracellular matrix;

wherein:

the first and second non-woven fiber compositions are configured to break down into one or more acidic byproducts when applied to a tissue site, and

the one or more acidic byproducts are selected from the group consisting of monomers and oligomers comprising: lactic acid, glycolic acid, 6-hydroxycaproic acid, caproic acid, 4-hydroxybutyrate, 2-hydroxyethoxyacetic acid, glyoxylic acid, and oxalic acid.

22 . The resorbable fiber matrix of claim 21 , wherein the first non-woven fiber composition to the second non-woven fiber composition ratio ranges from about 10:1 to about 1:10.

23 . The resorbable fiber matrix of claim 21 , wherein the first and second non-woven fiber compositions are commingled.

24 . The resorbable fiber matrix of claim 21 , wherein the first and second non-woven fiber compositions are configured to break down into one or more acidic byproducts via hydrolysis.

25 . The resorbable fiber matrix of claim 21 , wherein the one or more acidic byproducts create an acidic microenvironment, wherein the acidic microenvironment is configured to perform a function selected from the group consisting of: promote cell growth, promote antimicrobial activity, promote angiogenesis, modulate cellular and pathogenic activity, improve tissue oxygenation, promote epithelialization, promote the proliferation of fibroblasts, and migration of fibroblasts.

26 . The resorbable fiber matrix of claim 25 , wherein the acidic microenvironment is configured to promote cell growth, wherein promoting cell growth results in granulation tissue formation and/or neovascularization.

27 . The resorbable fiber matrix of claim 26 , wherein the first non-woven fiber composition is configured to break down into one or more acidic byproducts selected from the group consisting of monomers and oligomers comprising: lactic acid and glycolic acid.

28 . The resorbable fiber matrix of claim 27 , wherein the second non-woven fiber composition is configured to break down into one or more acidic byproducts selected from the group consisting of monomers and oligomers comprising: 6-hydroxycaproic acid, caproic acid, 2-hydroxyethoxyacetic acid, glyoxylic acid, and oxalic acid.

29 . The resorbable fiber matrix of claim 28 , wherein the second non-woven fiber composition is configured to break down into one or more acidic byproducts selected from the group consisting of monomers and oligomers comprising: 2-hydroxyethoxyacetic acid, glyoxylic acid, and oxalic acid.

30 . A resorbable fiber matrix comprising:

a first non-woven fiber composition and a second non-woven fiber composition, wherein the first and second non-woven fiber compositions each independently comprise a resorbable polymer;

wherein:

the resorbable fiber matrix comprises a plurality of pores comprising a mean pore size of from about 10 μm 2 to about 10,000 μm 2 ,

the first non-woven fiber composition and the second non-woven fiber composition each have a mean fiber diameter of less than 5 μm,

the resorbable fiber matrix has an architecture resembling a native extracellular matrix,

the first and second non-woven fiber compositions are configured to break down into one or more acidic byproducts when applied to a tissue site, and

the one or more acidic byproducts are selected from the group consisting of monomers and oligomers comprising: lactic acid, glycolic acid, 6-hydroxycaproic acid, caproic acid, 4-hydroxybutyrate, 2-hydroxyethoxyacetic acid, glyoxylic acid, and oxalic acid.

31 . The resorbable fiber matrix of claim 30 , wherein the first non-woven fiber composition to the second non-woven fiber composition ratio ranges from about 10:1 to about 1:10.

32 . The resorbable fiber matrix of claim 30 , wherein the first and second non-woven fiber compositions are commingled.

33 . The resorbable fiber matrix of claim 30 , wherein the first and second non-woven fiber compositions are configured to break down into one or more acidic byproducts via hydrolysis.

34 . The resorbable fiber matrix of claim 30 , wherein the one or more acidic byproducts create an acidic microenvironment, wherein the acidic microenvironment is configured to perform a function selected from the group consisting of: promote cell growth, promote antimicrobial activity, promote angiogenesis, modulate cellular and pathogenic activity, improve tissue oxygenation, promote epithelialization, promote the proliferation of fibroblasts, and migration of fibroblasts.

35 . The resorbable fiber matrix of claim 34 , wherein the acidic microenvironment is configured to promote cell growth, wherein promoting cell growth results in granulation tissue formation and/or neovascularization.

36 . The resorbable fiber matrix of claim 30 , wherein the first non-woven fiber composition is configured to break down into one or more acidic byproducts selected from the group consisting of monomers and oligomers comprising: lactic acid and glycolic acid.

37 . The resorbable fiber matrix of claim 36 , wherein the second non-woven fiber composition is configured to break down into one or more acidic byproducts selected from the group consisting of monomers and oligomers comprising: 6-hydroxycaproic acid, caproic acid, 2-hydroxyethoxyacetic acid, glyoxylic acid, and oxalic acid.

38 . The resorbable fiber matrix of claim 37 , wherein the second non-woven fiber composition is configured to break down into one or more acidic byproducts selected from the group consisting of monomers and oligomers comprising: 2-hydroxyethoxyacetic acid, glyoxylic acid, and oxalic acid.

39 . The resorbable fiber matrix of claim 30 , wherein the resorbable fiber matrix comprises interconnecting pores.

40 . The resorbable fiber matrix of claim 30 , wherein the pore size is configured to promote cellular infiltration, growth, and/or proliferation.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 12, 2026
From: ACERA SURGICAL, INC.
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 074933/0515 →
RELEASE OF SECURITY INTEREST Recorded Dec 23, 2025
From: WILSON FAMILY LEGACY TRUST NO. I
To: ACERA SURGICAL, INC.
Reel/Frame 073303/0131 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 15, 2025
From: MACEWAN, MATTHEW
To: ACERA SURGICAL, INC.
Reel/Frame 072580/0811 →